Patient-perceived risks of MS DMTs: Problems of communication and risk management?

In this issue of Neurology®, Fox et al.¹ consider the important issue of how patients with multiple sclerosis (MS) perceive the risk of a variety of adverse side effects from disease-modifying therapies (DMTs) in the context of a single specific treatment benefit. An understanding of patient perceptions of risk is a crucial aspect of patient-centered care and truly shared decision making. This is and will continue to be increasingly important given the welcome expansion in treatment options that also come with increasing complexity and potential for harm. It is an area of limited previous study.^2,3

from Neurology recent issues https://ift.tt/2FOHJSm